211 related articles for article (PubMed ID: 640366)
1. [Therapeutic abortions in the second trimestre of pregnancy with prostaglandine gel (author's transl)].
Heinzl S
Geburtshilfe Frauenheilkd; 1978 Mar; 38(3):220-6. PubMed ID: 640366
[TBL] [Abstract][Full Text] [Related]
2. [The induction of abortion and the priming of the cervix with prostaglandin F2 alpha and prostaglandin E2 by intra-amniotic, extra-amniotic and intra-cervical application (author's transl)].
Schmidt W; Widmaier G; Ditz S; Kubli F
Geburtshilfe Frauenheilkd; 1982 Feb; 42(2):118-22. PubMed ID: 6917804
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of two types of prostaglandins for abortion during the second trimester.
Rettenmaier MA; Hanson FW
Surg Gynecol Obstet; 1983 May; 156(5):585-8. PubMed ID: 6573807
[TBL] [Abstract][Full Text] [Related]
4. [Induction of abortion during the second and third trimester of pregnancy with sulprostone (author's transl)].
Heinzl S; Winkler C
Geburtshilfe Frauenheilkd; 1981 Mar; 41(3):231-6. PubMed ID: 7215768
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of extra-amniotic prostaglandin F2 alpha infusion and increasing intravenous oxytocin for termination of second trimester missed abortion.
Jaschevatzky OE; Rosenberg RP; Noy Y; Dascalu S; Anderman S; Ballas S
J Am Coll Surg; 1994 May; 178(5):435-8. PubMed ID: 8167879
[TBL] [Abstract][Full Text] [Related]
6. Termination of pregnancy by extraamniotic prostaglandins and the synergistic action of oxytocin.
Embrey MP; Hillier K; Mahendran P
Adv Biosci; 1973; 9():507-13. PubMed ID: 4805861
[TBL] [Abstract][Full Text] [Related]
7. [Cervix ripening and labor induction in therapeutic abortion in the middle and late 2d trimester using intracervical and extra-amniotic prostaglandin gel administration].
Rath W; Ulbrich R; Kuhn W
Wien Klin Wochenschr; 1985 May; 97(11):486-93. PubMed ID: 3859953
[TBL] [Abstract][Full Text] [Related]
8. Midtrimester abortion with urea, prostaglandin F2alpha, laminaria, and oxytocin. A new regimen.
Wilson WB
Obstet Gynecol; 1978 Jun; 51(6):699-701. PubMed ID: 662249
[TBL] [Abstract][Full Text] [Related]
9. Abortion-inducing effect of prostaglandin F2-alpha in the mid-trimester of pregnancy.
Pajor A; Zsolnai B
Acta Chir Hung; 1984; 25(4):229-38. PubMed ID: 6596819
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic interruption of pregnancy in the second trimester after preparation of the cervix with prostaglandins F2 alpha].
Maria B; Stampf F; Barrat J
J Gynecol Obstet Biol Reprod (Paris); 1983; 12(5):545-52. PubMed ID: 6581224
[TBL] [Abstract][Full Text] [Related]
11. Comparison between intraamniotic PGF2 alpha and vaginal PGE2 for second-trimester abortion.
Lebed JP; Rubin A; Millman AE
Obstet Gynecol; 1980 Jul; 56(1):90-6. PubMed ID: 7383493
[TBL] [Abstract][Full Text] [Related]
12. Double-balloon instillation device for second-trimester abortion. Outcome in 340 consecutive cases.
Abramovici H; Bornstein J; Ben-David Y; Yishai D; Rofe A; Atad J
J Reprod Med; 1995 Jan; 40(1):56-62. PubMed ID: 7722978
[TBL] [Abstract][Full Text] [Related]
13. [Comparative studies on the termination of intact and disturbed pregnancies by intramuscular application of 15(s)-15-methyl-prostaglandin F2alpha (author's transl)].
Schridde H; Hickl EJ
Geburtshilfe Frauenheilkd; 1978 Oct; 38(10):845-8. PubMed ID: 700344
[TBL] [Abstract][Full Text] [Related]
14. [A new therapeutic approach for terminating intact and disturbed pregnancies: three years of experience with the prostaglandin E2-derivative sulprostone (SHB 286) (author's transl)].
Schmidt-Gollwitzer K; Schüssler B; Elger W; Schmidt-Gollwitzer M
Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):667-75. PubMed ID: 478268
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic induction of abortion in the 1st and 2nd trimesters with intramuscular 15-methyl-prostaglandin F2 alpha].
Göretzlehner G; Rudolf K; Frahm R
Zentralbl Gynakol; 1977; 99(22):1356-60. PubMed ID: 602503
[TBL] [Abstract][Full Text] [Related]
16. Intrauterine PGF2 alpha infusion for termination of pregnancies with second-trimester rupture of membranes.
Jaschevatzky OE; Dascalu S; Noy Y; Rosenberg RP; Anderman S; Ballas S
Obstet Gynecol; 1992 Jan; 79(1):32-4. PubMed ID: 1727581
[TBL] [Abstract][Full Text] [Related]
17. Hormone release and abortifacient effectiveness of a newly developed silastic device containing 15-ME-PGF2alpha methyl ester in concentrations of 0.5% and 1.0%.
Lauersen NH; Wilson KH
Prostaglandins; 1976; 12 Suppl():63-79. PubMed ID: 968066
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic abortion during the second trimester of pregnancy, using intracervical injection of PgF2 alpha (author's transl)].
Maria B; Blot P; Sureau C
Nouv Presse Med; 1981 May; 10(22):1825-7. PubMed ID: 7232171
[TBL] [Abstract][Full Text] [Related]
19. Extraamniotic intermittent administration of prostaglandin F2 alpha during the first and second trimesters of pregnancy.
Goeretzlehner G; Rudolf K; Kyank H; Frahm R
Ann Chir Gynaecol; 1979; 68(3):100-3. PubMed ID: 533211
[TBL] [Abstract][Full Text] [Related]
20. Termination of pregnancy in patients with missed abortion and intrauterine dead fetuses by a single intracervical application of prostaglandin E2 in viscous gel.
Ekman G; Forman A; Ulmsten U; Wingerup L
Zentralbl Gynakol; 1980; 102(4):219-22. PubMed ID: 7467962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
